LAUNXP Biomedical , Ltd Total Current Liabilities

The latest total current liabilities for 6876.TWO is $140M as of June 2026. That compares with $270M in the prior-year period — down 49.3% year over year. Investors often review this figure alongside LAUNXP Biomedical , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6876.TWO's total current liabilities moved from $270M to $140M — a 49.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LAUNXP Biomedical , Ltd's operating scale or balance-sheet position.

A total current liabilities figure of $140M for 6876.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6876.TWO's total current liabilities ($140M), review year-over-year change from $270M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack LAUNXP Biomedical , Ltd's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.